selenium in Hashimoto

Phase 2

• Conditions: Condition 1: Autoimmune thyroiditis,. Condition 2: Nontoxic goiter, unspecified.; Autoimmune thyroiditis; Nontoxic goiter, unspecified

• Registration Number: IRCT20180510039601N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 July 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

female
age 30_60 years
Anti TPO positive
4>TSH >.4 mU/L
0.25goiter
24 hours Urine Iodine >100 microgram/

Exclusion Criteria

pregnancy
under treatment with Anti thyroid medicines
taking supplement contain of selenium

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thyroid size (Length x width × Anterior posterior diameters × p / 6). Timepoint: thyroid size( Length x width × Anterior posterior diameters × p / 6 ) before and 3 month after intervention by sonography. Method of measurement: sonography.

Secondary Outcome Measures

Name	Time	Method
Anti TPO level. Timepoint: AntiTPO measured before and 3 month after intervention. Method of measurement: labratory.